Literature DB >> 15139983

Isolated antibodies against the core antigen of hepatitis B virus in HIV-infected patients.

D Neau1, M Winnock, T Galpérine, A C Jouvencel, L Castéra, E Legrand, E Tranchant, E Balestre, D Lacoste, J M Ragnaud, M Dupon, M E Lafon, F Dabis.   

Abstract

The aim of this study was to describe the frequency and significance of isolated antibodies against the hepatitis B virus (HBV) core antigen (HBc) in 2185 HIV-infected patients of the Aquitaine Cohort. Antibodies against HBc were found in 372 subjects (17%). Patients with isolated anti-HBc antibodies were more frequently coinfected with hepatitis C virus (HCV) (58.2%) than those who were anti-HB surface (HBs) antibody positive (22.9%, P<0.001) and those who were dually reactive anti-HBs/anti-HBc antibody positive (27.3%, P<0.001). These results suggest interactions between HBV and HCV. As observed in patients not infected with HIV, the "anti-HBc-alone" serological profile could reflect essentially late immunity with undetectable anti-HBs antibodies. However, an occult HBV infection cannot be ruled out.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15139983     DOI: 10.1111/j.1468-1293.2004.00206.x

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  12 in total

Review 1.  Hepatitis B virus vaccination in HIV-infected people: A review.

Authors:  François-Xavier Catherine; Lionel Piroth
Journal:  Hum Vaccin Immunother       Date:  2017-02-16       Impact factor: 3.452

2.  Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy.

Authors:  Andrea Costantini; Katia Marinelli; Giulia Biagioni; Alessia Monachetti; Monica L Ferreri; Luca Butini; Maria Montroni; Aldo Manzin; Patrizia Bagnarelli
Journal:  BMC Infect Dis       Date:  2011-11-04       Impact factor: 3.090

3.  Isolated hepatitis B core antibody is associated with HIV and ongoing but not resolved hepatitis C virus infection in a cohort of US women.

Authors:  Audrey L French; Eva Operskalski; Marion Peters; Howard D Strickler; Phyllis C Tien; Gerald B Sharp; Marshall J Glesby; Mary Young; Michael Augenbraun; Eric Seaberg; Andrea Kovacs
Journal:  J Infect Dis       Date:  2007-04-05       Impact factor: 5.226

4.  Prevalence and characteristics of hepatitis B and C virus infections in treatment-naïve HIV-infected patients.

Authors:  Stefan Reuter; Mark Oette; Frank Clemens Wilhelm; Bastian Beggel; Rolf Kaiser; Melanie Balduin; Finja Schweitzer; Jens Verheyen; Ortwin Adams; Thomas Lengauer; Gerd Fätkenheuer; Herbert Pfister; Dieter Häussinger
Journal:  Med Microbiol Immunol       Date:  2010-09-19       Impact factor: 3.402

5.  Prevalence and long-term effects of occult hepatitis B virus infection in HIV-infected women.

Authors:  Judith I Tsui; Audrey L French; Eric C Seaberg; Michael Augenbraun; Marek Nowicki; Marion Peters; Phyllis C Tien
Journal:  Clin Infect Dis       Date:  2007-08-10       Impact factor: 9.079

6.  Predictors of the isolated hepatitis B core antibody pattern in HIV-infected and -uninfected men in the multicenter AIDS cohort study.

Authors:  Mallory D Witt; Roger J Lewis; Gunter Rieg; Eric C Seaberg; Charles R Rinaldo; Chloe L Thio
Journal:  Clin Infect Dis       Date:  2012-10-22       Impact factor: 9.079

7.  Clinical significance of "anti-HBc alone" in human immunodeficiency virus-positive patients.

Authors:  Ma Teresa Pérez-Rodríguez; Bernardo Sopeña; Manuel Crespo; Alberto Rivera; Teresa González del Blanco; Antonio Ocampo; César Martínez-Vázquez
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

8.  Prevalence, risk factors, and impact of isolated antibody to hepatitis B core antigen and occult hepatitis B virus infection in HIV-1-infected pregnant women.

Authors:  Woottichai Khamduang; Nicole Ngo-Giang-Huong; Catherine Gaudy-Graffin; Gonzague Jourdain; Weerapong Suwankornsakul; Tapnarong Jarupanich; Veeradate Chalermpolprapa; Sirisak Nanta; Noossara Puarattana-Aroonkorn; Sakchai Tonmat; Marc Lallemant; Alain Goudeau; Wasna Sirirungsi
Journal:  Clin Infect Dis       Date:  2013-03-13       Impact factor: 9.079

9.  Seroprevalence of Hepatitis B and C Viruses Among Children in Kilimanjaro Region, Tanzania.

Authors:  Florida J Muro; Suzanne P Fiorillo; Philoteus Sakasaka; Christopher Odhiambo; Elizabeth A Reddy; Coleen K Cunningham; Ann M Buchanan
Journal:  J Pediatric Infect Dis Soc       Date:  2013-04-12       Impact factor: 3.164

10.  "Anti-HBc alone" in human immunodeficiency virus-positive and immuno-suppressed lymphoma patients.

Authors:  Yu Xuan Koo; Daniel S W Tan; Iain B H Tan; Richard Quek; Miriam Tao; Soon Thye Lim
Journal:  World J Gastroenterol       Date:  2009-08-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.